CD38 and chronic myelogenous leukemia, BCR-ABL1 positive: Later, the same group performed an RNA-seq study aimed to identify additional, cell surface markers differentially expressed between CML CD34+CD38-, CD34+CD38+ and their counterparts in normal BM that identified CD36 as specifically upregulated in primitive CML cells [38].